Skip Navigation

Cardiovascular Research 2001 51(1):13-20; doi:10.1016/S0008-6363(01)00250-4
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bing, R. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bing, R. J
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Myocardial ischemia and infarction: growth of ideas

Richard J Bing*

Department of Experimental Cardiology, Huntington Medical Research Institutes, 99 North El Molino Avenue, Pasadena, CA 91101, USA

* Tel.: +1-626-397-5860; fax: +1-626-795-5774

This report reviews the author's involvement in the growth of ideas and basic concepts in myocardial ischemia resulting in the histological changes of myocardial infarction. Concepts arising from the study of myocardial substrate utilization, activation of the inducible form of nitric oxide synthase and production of prostacyclin and thromboxane in the infarcted heart are presented. New approaches are discussed dealing with the effects of nonsteroidal anti-inflammatory drugs on myocardial production of nitric oxide and prostanoids, and with the relevance of the inducible form of cyclooxygenase. The review also records a number of significant similarities between angiogenesis in the ischemic heart and some cancers. Angiogenesis in both instances originates from inflammatory reactions, illustrating how different tissues and organs such as ischemic heart muscle and cancer react to similar pathological stimuli in an identical manner. This multifocal approach opens new concepts on myocardial ischemia and cancer.

KEYWORDS Angiogenesis; Coronary disease; Infarction; Macrophages; Prostaglandins


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
G. Takemura, M. Nakagawa, H. Kanamori, S. Minatoguchi, and H. Fujiwara
Benefits of reperfusion beyond infarct size limitation
Cardiovasc Res, July 15, 2009; 83(2): 269 - 276.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C.-P. Hsu, C.-Y. Huang, J.-S. Wang, P.-C. Sun, and C.-C. Shih
Extracellular Matrix Remodeling Attenuated After Experimental Postinfarct Left Ventricular Aneurysm Repair
Ann. Thorac. Surg., October 1, 2008; 86(4): 1243 - 1249.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Y. Mizukami, K. Ono, C.-K. Du, T. Aki, N. Hatano, Y. Okamoto, Y. Ikeda, H. Ito, K. Hamano, and S. Morimoto
Identification and physiological activity of survival factor released from cardiomyocytes during ischaemia and reperfusion
Cardiovasc Res, September 1, 2008; 79(4): 589 - 599.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
S. Philipp, J. S. Jurgensen, J. Fielitz, W. M. Bernhardt, A. Weidemann, A. Schiche, B. Pilz, R. Dietz, V. Regitz-Zagrosek, K.-U. Eckardt, et al.
Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats
Eur J Heart Fail, June 1, 2006; 8(4): 347 - 354.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
D. Vanhoutte, M. Schellings, Y. Pinto, and S. Heymans
Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window
Cardiovasc Res, February 15, 2006; 69(3): 604 - 613.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Philipp, L. Cui, B. Ludolph, M. Kelm, R. Schulz, M. V. Cohen, and J. M. Downey
Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H450 - H457.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. Van Oosterom, and E. A. De Bruijn
Vascular Endothelial Growth Factor and Angiogenesis
Pharmacol. Rev., December 1, 2004; 56(4): 549 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. I. Virag and C. E. Murry
Myofibroblast and Endothelial Cell Proliferation during Murine Myocardial Infarct Repair
Am. J. Pathol., December 1, 2003; 163(6): 2433 - 2440.
[Abstract] [Full Text]

Home page
 J Am Coll CardiolHome page
R. J. Bing and M. Lomnicka
Why do cyclo-oxygenase-2 inhibitors cause cardiovascular events?
J. Am. Coll. Cardiol., February 6, 2002; 39(3): 521 - 522.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.